Podcasts about Medical college

In this episode of the podcast, Dr. David Puder sits down with Dr. Karen Maroda, a renowned psychoanalyst, assistant professor of psychiatry at the Medical College of Wisconsin, and author of influential books including The Power of Countertransference and The Analyst's Vulnerability. Together they explore a powerful clinical insight: disengagement precedes enactment. Learn how therapists' unprocessed countertransference (irritation, boredom, guilt, anger, or helplessness) often leads to emotional withdrawal before erupting into destructive enactments that can rupture the therapeutic relationship. Dr. Maroda shares candid examples from her own practice, including a personal enactment she later processed with her patient, and demonstrates practical strategies for catching disengagement early, using constructive self-disclosure, and maintaining emotional presence. The conversation features a live role-play, deep discussion of parentification in therapists' histories, setting healthy boundaries, managing guilt and shame, and turning potential pitfalls into opportunities for deeper connection.   By listening to this episode, you can earn 1.25 Psychiatry CME Credits. Link to blog Link to YouTube video

Al and the Future of Plastic Surgery Artificial Intelligence is transforming industries around the world, and plastic surgery is no exception. In this episode of the Looking Good Feeling Great Podcast, host Dr. Jeffrey Roth of Las Vegas Plastic Surgery and co-host Darrell Craig Harris explore how Al is beginning to impact patient consultations, surgical planning, imaging technology, practice management, and the overall patient experience. Dr. Roth shares his perspective on the opportunities and limitations of Al in aesthetic medicine, discussing where technology can enhance outcomes and where the expertise, judgment, and artistry of a board-certified plastic surgeon remain irreplaceable. Whether you're considering a cosmetic procedure, work in healthcare, or are simply fascinated by the future of technology, this episode offers an insightful look at the evolving relationship between artificial intelligence and plastic surgery. Meet Dr. Jeffrey J. Roth from Las Vegas Plastic Surgery Drawn to medicine by his innate desire to help others, he received his medical degree from the University of Nevada School of Medicine. He completed his general surgery residency at the Medical College of Pennsylvania/Hahnemann University in Philadelphia and his plastic surgery residency at the University of California, San Francisco, serving as chief resident in both programs. He then furthered his training with a fellowship in microsurgery and hand surgery at USC, where he also served on the faculty. Having gathered the kind of expertise and experience that makes him a leader in his field, Dr. Roth returned to Las Vegas in 2003 and opened his practice, Las Vegas Plastic Surgery, Inc. Website www.JJRothMD.com  Social media www.Instagram.com/lasvegasplasticsurgery www.Instagram.com/lookinggoodfeelinggreatpodcast www.Facebook.com/lasvegasplasticsurgery www.Twitter.com/DrJeffreyRoth             

As we age, fragility, frailty, and mobility become crucial aspects of our well-being. Understanding these challenges helps us navigate ageing with dignity, strength, and independence. In this insightful episode of Ageing Gracefully, Fr. Juventius Andrade hosts a discussion with two distinguished experts:

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes Brad Karon, M.D., Ph.D., division chair for Mayo Clinic's Clinical Core Laboratory Services and a member of the laboratory and pathologist stewardship team, to discuss laboratory stewardship strategies and why they matter.Why lab stewardship is important (00:44): How improved test utilization benefits laboratories, healthcare systems, and patients.Strategies for promoting lab stewardship (03:40): Proven approaches for improving appropriate test utilization.How industry disrupters will change stewardship efforts (09:33): How artificial intelligence and other emerging disruptors may reshape lab stewardship efforts.Note: Information in this post was accurate at the time of its posting.ResourcesFroedtert and the Medical College of Wisconsin: Promoting laboratory stewardship through clinical decision supportFive steps to optimizing your outreach test menuHospital-owned labs generate long-term financial and clinical value

Dr. Tara Sander Lee is a Founding Board Member of SALT, Science Alliance for Life and Technology. She is a Science Advisor and Consultant who earned her Ph.D. in Biochemistry from the Medical College of Wisconsin. She has over 30 years' experience in public policy, academic research and clinical medicine with an emphasis on the cause of pediatric disease There are numerous debates as to how far we can delve into scientific research and still hold to a system of ethics. Some say it really doesn't matter as long as it's for the common good. Take, for instance, embryonic stem cell research. Some will claim that since aborted baby tissue would otherwise go in the trash, it's fine to use it for experimentation. Others contend the use of fetal body parts from aborted babies in vaccines and treatment are also okay if others are being helped by it. Did you know there are labs that create human embryos solely for experiments? These embryos are usually destroyed once research is complete. Also, did you know aborted fetal tissue is still used in some medical studies? This research often happens without public awareness or consent. And what about the use of AI? AI tools are shaping choices in healthcare, pregnancy and research. If left unchecked, this can target those who are disabled, the unborn or even older adults. We are headed down a pathway of very concerning technologies, genetic screening, gene editing, cloning, artificial wombs, 3-parent embryos and even human-animal chimeras. Where do we draw the line? When is it time to put the brakes on scientific research to protect ethics and prevent us from going down the pathway of eugenics?

Dr. Tara Sander Lee is a Founding Board Member of SALT, Science Alliance for Life and Technology. She is a Science Advisor and Consultant who earned her Ph.D. in Biochemistry from the Medical College of Wisconsin. She has over 30 years' experience in public policy, academic research and clinical medicine with an emphasis on the cause of pediatric disease There are numerous debates as to how far we can delve into scientific research and still hold to a system of ethics. Some say it really doesn't matter as long as it's for the common good. Take, for instance, embryonic stem cell research. Some will claim that since aborted baby tissue would otherwise go in the trash, it's fine to use it for experimentation. Others contend the use of fetal body parts from aborted babies in vaccines and treatment are also okay if others are being helped by it. Did you know there are labs that create human embryos solely for experiments? These embryos are usually destroyed once research is complete. Also, did you know aborted fetal tissue is still used in some medical studies? This research often happens without public awareness or consent. And what about the use of AI? AI tools are shaping choices in healthcare, pregnancy and research. If left unchecked, this can target those who are disabled, the unborn or even older adults. We are headed down a pathway of very concerning technologies, genetic screening, gene editing, cloning, artificial wombs, 3-parent embryos and even human-animal chimeras. Where do we draw the line? When is it time to put the brakes on scientific research to protect ethics and prevent us from going down the pathway of eugenics?

OsteoBites welcomes Caroline Maloney, MD, PhD, from the Medical College of Wisconsin, who will discuss her research on surgery-accelerated metastasis and developing perioperative therapies.Pulmonary metastasis remains the major cause of death in osteosarcoma. The timing of metastatic relapse defines clinically meaningful subgroups in osteosarcoma with patients who relapse within 6–12 months of surgical removal of their primary tumor having markedly worse survival (10-20%) than those who relapse after completion of therapy (40-50%). While surgical removal of the primary tumor is a fundamental component of the clinical care of solid tumors, surgery induces transient but profound changes in immune and inflammatory responses that can paradoxically accelerate the growth of metastatic disease. Dr. Maloney has demonstrated that surgical removal of the primary tumor accelerates the growth of pre-existing pulmonary metastatic disease and promotes expansion of M2‐like macrophages in the lung microenvironment. Strikingly, short term perioperative treatment with a RIPK2 inhibitor blocks this effect and reprograms macrophages toward an M1-like phenotype, implicating the NOD2–RIPK2 innate immune pathway as a key mediator of post‐surgical immune reprogramming. In contrast, the NOD2 agonist Mifamurtide has shown clinical efficacy when administered as adjuvant therapy to metastatic osteosarcoma patients after primary tumor resection. This data suggests that NOD/RIPK2 signaling may exert context-dependent effects, promoting either pro- or anti-tumor myeloid responses depending on the timing of activation relative to surgery. Understanding how surgical tumor removal alters systemic innate immunity and how RIPK2 signaling orchestrates these responses could identify new strategies to prevent early pulmonary relapse after surgery.

Hey, Doc! What's Wrong with My Eye?: A General Guide to Eye Symptoms by John C Barber, MD, FAAOThis book is a primer on eye disease. It is written for the nonphysician but would benefit physicians and paramedical personnel who are not eye physicians. Dr. Barber explains the common signs and symptoms of eye diseases and explains the usual treatments for these diseases, including glaucoma, cataracts, macular degeneration, and strabismus. It contains chapters about the ways diabetes, thyroid disease, AIDS, and other systemic diseases affect the eye. Several chapters explain the surgery for correction of cataracts, retinal detachment, crooked eyes, and glaucoma. There is a section on eye diseases of childhood. This book is recommended for employees in ophthalmic offices to better understand patient problems and the doctor's treatments.Dr Barber has had a career in medical education serving as Chairman of Ophthalmology at The University of Texas in Galveston and St. Francis Medical Center in Pittsburgh. He trained at Washington University in St. Louis, Medical College of Virginia and Massachusetts Eye and Ear Infirmary (Harvard)..He prides himself in being able to explain complicated diseases ant treatments in common understandable language for the average person.AMAZONhttp://johncbarber.com/https://leavittpeakpress.com/http://www.bluefunkbroadcasting.com/root/twia/42326lpp.mp3    

Join Elevated GP: www.theelevatedgp.com Connect with me on Instagram at @dr.melissa_seibert on Instagram Van B. Haywood, D.M.D., is Professor Emeritus in the Department of Restorative Sciences, Dental College of Georgia @ Augusta University.  A 1974 alumni of the Medical College of Georgia School of Dentistry, he was in private practice 7 years in Augusta, Georgia and taught at the University of North Carolina School of Dentistry in Chapel Hill, NC in Operative and Prosthodontics for 12 years before coming to Augusta University in 1993. In 1989, he co-authored the first publication in the world on Nightguard vital bleaching (at-home tray bleaching) with Dr. Harald Heymann, and in 1997 co-authored the first article on extended treatment (six-months) of tetracycline-stained teeth using this technique.While he is most known for his research and articles on tray bleaching, he taught in the Fixed Prosthodontics courses, the Occlusion courses,and the Esthetics course, as well as in sophomore and junior Operative and Fixed student clinics. After over 29 years at the Dental College of Georgia, he retired from full-time teaching in December 2022. The DCG Class of 1997 initiated a scholarship in his name for clinical excellence and compassionate care.

My guest today on the Online for Authors podcast is Janis Robinson Daly, author of the book Under Two Flags. Splitting her time between Cape Cod, New Hampshire, and snowbird destinations, a tablet becomes Janis Robinson Daly's library and desk, packed for reading and writing, wherever she might land. Inspired by the discovery that an ancestor founded the Woman's Medical College of PA in 1850, Daly wrote her first novel, The Unlocked Path, which celebrates pioneering women doctors at the turn of the 20th Century. Its sequel, The Path Beneath Her Feet, honors the work of the American Women's Hospitals in rural America during the 1930s. Her third book with Black Rose is scheduled for a March 2026 release. Another historical fiction, Under Two Flags is a re-write and retelling of a memoir of a young Boston woman who travels to Berlin in 1916 to study opera. The original memoir, published in 1918, was ghostwritten by Daly's grandfather, Eliot H. Robinson, Sr.   Daly graduated with a B.A. in Psychology from Wheaton College, at the time, a women's college. At Wheaton, she developed a fond appreciation of the supportive relationships established between students and a heightened awareness of female-centric issues. A presentation of how her genealogy research inspired her to begin writing has made Daly a sought-after speaker for book clubs, women's groups, libraries, and writers' groups.   Her annual literary citizenship program, #31titleswomeninhistory, has gained recognition from historical fiction authors and avid readers as an innovative way to celebrate Women's History Month in March.   In my book review, I stated Under Two Flags is a historical fiction by Janis Robinson Daly. And Josephine? She is a character you will want to meet! She is the daughter of US immigrants who embraced all things American. Her mother gave up a promising career as an opera singer and her father built a business from nothing. Josephine, having her mother's singing gift, believed she, too, might be an opera singer until her father's death changed everything. Now, as WWI erupts in Europe, Josephine is given a chance of a lifetime - to study opera in Germany at the same school her mother had been forced to leave.   As with most adventures, Josephine arrives wearing rose colored glasses, assuming the war would be a mere inconvenience. However, she quickly learns the war permeates every aspect of German life. And as an American, she was suspect - a privileged oddity at best and a potential spy at worst.   What happens when the US enters the war? When a German solider takes a fancy to Josephine? When one of Josephine's friends is accused of being a spy? When the cold and hunger leave her weak with anemia? When her teachers find her too American? When being Jewish clashes with food rations? When homesickness makes her rethink all of her choices? When going home is no longer a choice?   Under Two Flags is a fictionalized version of a real woman during WWI - and it's a story you won't want to miss.   Subscribe to Online for Authors to learn about more great books! https://www.youtube.com/@onlineforauthors?sub_confirmation=1   Join the Novels N Latte Book Club community to discuss this and other books with like-minded readers: https://www.facebook.com/groups/3576519880426290   You can follow Author Janis Robinson Daly Website: https://janisrdaly.com/ FB: @JanisRobinsonDalyAuthor IG: @janisrdaly_writer   Purchase Under Two Flags on Amazon: Paperback: https://amzn.to/4qvihEK Ebook: https://amzn.to/3MbjEu9   Teri M Brown, Author and Podcast Host: https://www.terimbrown.com FB: @TeriMBrownAuthor IG: @terimbrown_author X: @terimbrown1   Want to be a guest on Online for Authors? Send Teri M Brown a message on PodMatch, here: https://www.podmatch.com/member/onlineforauthors   #janisrobinsondaly #undertwoflags #historicalfiction #terimbrownauthor #authorpodcast #onlineforauthors #characterdriven #researchjunkie #awardwinningauthor #podcasthost #podcast #readerpodcast #bookpodcast #writerpodcast #author #books #goodreads #bookclub #fiction #writer #bookreview *As an Amazon Associate I earn from qualifying purchases.

The wellness industry has a problem, and Ezekiel Emanuel is one of the few people willing to call it out. In his new book, Eat Your Ice Cream: A Contrarian’s Guide to Living Longer, Healthier, and Happier, the bioethicist, oncologist, and former White House health advisor challenges both the influencers selling unproven supplements and the culture of wellness-as-self-punishment. In this episode, Emanuel makes a compelling research-backed case that the single most powerful determinant of health, longevity, and happiness is social connection, not sleep scores, protein intake, or VO2 max. Drawing on the Harvard Adult Development Study, the longitudinal study, going strong after 88 years, and other research worldwide, he explains why loneliness is biologically dangerous, and why doctors almost never ask about it. He also makes important points about retirement. When 40 hours of purposeful work becomes 40 hours of passive television, the brain pays a price. Emanuel argues that retirement requires deliberate design to replace the cognitive challenge, social contact, and structured schedule that work once provided. And he offers Ben Franklin, inventor of bifocals at 79, and still inventing at 81, as a model for what staying fully alive in later life actually looks like. Ezekiel Emanuel joins us from Washington, DC. ________________________ For More on Ezekiel Emanuel Eat Your Ice Cream: A Contrarian’s Guide to Living Longer, Healthier, and Happier Website ________________________ Bio Ezekiel J. Emanuel, MD, PhD, is the Vice Provost for Global Initiatives and the Diane v.S. Levy and Robert M. Levy University Professor. An oncologist and world leader in health policy and bioethics, he is a Special Advisor to the Director General of the World Health Organization, Senior Fellow at the Center for American Progress, and member of the Council on Foreign Relations. He was the founding chair of the Department of Bioethics at the National Institutes of Health and held that position until August 2011. From 2009 to 2011, he served as a Special Advisor on Health Policy to the Director of the Office of Management and Budget and National Economic Council. In this role, he was instrumental in drafting the Affordable Care Act. Dr. Emanuel is the most widely cited bioethicist in history. He has over 350 publications and has authored or edited 15 books. His recent publications include Which Country Has the World's Best Health Care (2020), Prescription for the Future (2017), Reinventing American Health Care: How the Affordable Care Act Will Improve our Terribly Complex, Blatantly Unjust, Outrageously Expensive, Grossly Inefficient, Error Prone System (2014) and Brothers Emanuel: A Memoir of an American Family (2013). In 2008, he published Healthcare, Guaranteed: A Simple, Secure Solution for America, which included his own recommendations for health care reform.Dr. Emanuel regularly contributes to The New York Times, The Washington Post, The Wall Street Journal, and The Atlantic and often appears on BBC, NPR, CNN, MS NOW and other media outlets. He has received numerous awards, including election to the Institute of Medicine (IOM) of the National Academy of Science and awards from the American Academy of Arts and Sciences, the Association of American Physicians, and the Royal College of Medicine (UK). He has been named a Dan David Prize Laureate in Bioethics and is a recipient of the AMA-Burroughs Wellcome Leadership Award, the Public Service Award from the American Society of Clinical Oncology, the Lifetime Achievement Award from the American Society of Bioethics and Humanities, the Robert Wood Johnson Foundation David E. Rogers Award, the President's Medal for Social Justice from Roosevelt University, and the John Mendelsohn Award from the MD Anderson Cancer Center, as well as honorary degrees from Icahn School of Medicine at Mount Sinai, Union Graduate College, the Medical College of Wisconsin, and Macalester College. Dr. Emanuel is a graduate of Amherst College. He holds a M.Sc. from Oxford University in Biochemistry and received his M.D. from Harvard Medical School and a Ph.D. in political philosophy from Harvard University. ________________________ Retirement Podcast Conversations You’ll Also Love   The Good Life – Marc Schulz, PhD Retiring: Creating a Life That Works for You – Teresa Amabile How Not to Age – Dr. Michael Greger _________________________ About The Retirement Wisdom Podcast There are many podcasts on retirement, often hosted by financial advisors with their own financial motives, that cover the money side of the street. This podcast is different. You'll get smarter about the investment decisions you'll make about the most important asset you'll have in retirement: your time. About Retirement Wisdom I help people who are retiring, but aren't quite done yet, discover what's next and build their custom version of their next life. A meaningful retirement doesn't just happen by accident. Schedule a call today to discuss how the Designing Your Life process created by Bill Burnett & Dave Evans can help you make your life in retirement a great one — on your own terms. About Your Podcast Host Joe Casey is an executive coach who helps people design their next life after their primary career and create their version of The Multipurpose Retirement.™ He created his own next chapter after a 26-year career at Merrill Lynch, where he was Senior Vice President and Head of HR for Global Markets & Investment Banking. Joe has earned Master's degrees from the University of Southern California in Gerontology (at age 60), the University of Pennsylvania, and Middlesex University (UK), a BA in Psychology from the University of Massachusetts at Amherst, and his coaching certification from Columbia University. In addition to his work with clients, Joe hosts The Retirement Wisdom Podcast, ranked in the top 1% globally in popularity by Listen Notes, with over 2 million downloads. Business Insider recognized Joe as one of 23 innovative coaches who are making a difference. He's the author of Win the Retirement Game: How to Outsmart the 9 Forces Trying to Steal Your Joy. __________________________ Wise Quotes On Wellness “Wellness should be about joie de vivre — about joy in life. It should not be only self-deprivation…Most of wellness is about don’t do stupid stuff — and most of it, we already know.” On Retirement “Most people when 40 hours of work drops out, 40 hours of TV comes in. Very passive. Not very intellectually challenging. That’s not retirement — that’s a slow decline…We don’t spend nearly enough time thinking about the brain part of retirement. Your brain is probably more important than your money.” On Willpower vs. Habits “If you have to use your willpower every time you do something, you can forget it. You have to make the wellness activity part of your habit. Doing it three to four times a week for about six weeks, that’s about what you need for a new activity to become ingrained.”  

Dr. Merritt Tuttle is both a Pediatric Intensivist and Medical Toxicologist at Brenner Children's Hospital in North Carolina associated with Atrium Health and Wake Forest Baptist Health. She completed her Pediatric Critical Care and Medical Toxicology training at the Medical College of Wisconsin.Learning Objective: By the end of this podcast, listeners should be able to discuss an evidence based and expert guided approach to the evaluation and management of the critically ill child with calcium channel blocker toxicity.References:St-Onge M, Anseeuw K, Cantrell FL et al, Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults. Crit Care Med. 2017 Mar;45(3):e306-e315.2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular CareLevine M, Curry SC, Padilla-Jones A, Ruha AM. Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: a 25-year experience at a single center. Ann Emerg Med. 2013 Sep;62(3):252-8. doi: 10.1016/j.annemergmed.2013.03.018. Cole JB, Arens AM, Laes JR, Klein LR, Bangh SA, Olives TD. High dose insulin for beta-blocker and calcium channel-blocker poisoning. Am J Emerg Med. 2018 Oct;36(10):1817-1824. doi: 10.1016/j.ajem.2018.02.004. Epub 2018 Feb 6.Slamowitz A, Sweberg T, Labgold K, Nickerson T. Extracorporeal Membrane Oxygenation for Calcium Channel Blocker Intoxication: A Multicenter Retrospective Registry Review. ASAIO J. 2025 Oct 31. Poison Control: (800) 222-1222Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show.Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com.  You can also check out our website at http://www.pedscrit.com. Thank you for listening to this episode of PedsCrit!

In today's episode, we sit down with Dr. Aaron Hartman to discuss his book, UnCurable: From Hopeless Diagnosis to Defying All Odds. As a board-certified physician, clinical researcher, and founder of Richmond Integrative & Functional Medicine, Dr. Hartman's path took a profound turn after adopting his daughter, Anna, who was diagnosed with severe neurological injury and cerebral palsy and labeled "incurable." Her unexpected progress challenged those assumptions and ultimately led him to embrace functional and precision medicine as a new framework for healing. Dr. Hartman was trained in conventional family medicine and earned his MD from the Medical College of Virginia. He also served as a Major in the U.S. Air Force, where he oversaw medical clinics in both the United States and Europe and received additional training in cardiology, dermatology, and nuclear and biological warfare medicine. Throughout his career, Dr. Hartman has participated in more than 70 clinical trials, published research including work in The Lancet, and cared for patients across four continents in more than 100,000 clinical encounters. He is triple board-certified, with advanced credentials in integrative, functional, metabolic, regenerative, and anti-aging medicine, and he previously served as an Assistant Clinical Professor of Family Medicine at Virginia Commonwealth University. Join the conversation to learn more about: The three pillars of healing with functional medicine. The ways that diet can heal disease. How to holistically cure conditions outside the boundaries of conventional medicine.  The intersection of gut health and brain health.  This episode offers a thoughtful look at the evolving boundaries of modern healthcare, and what it means to rethink a diagnosis once considered final. You can connect with Dr. Hartman on Instagram at @aaronhartmanmd.

Earlier this month, Prime Minister Modi highlighted the growing importance of the care economy – a rising demand for caregivers globally and an opportunity to train and skill young people to meet this demand. India stands at a unique position here – despite having the largest youth population in the world, it is also a rapidly ageing country. Estimates indicate that by 2050, we will have over 300 million people aged over 60. With this, will come an increasing number of medical conditions related to old age. The question now is, do we have the health and care resources to cater to these growing population segment? Do we have enough geriatricians? Does our medical curriculum focus enough on geriatric medicine? Do we have adequate community care-based systems to take care of our senior citizens? Guest: Dr Arvind Kasthuri, Head of Unit, St John's Geriatric Centre and Professor, Department of Community Health, St John's Medical College, Bengaluru Host: Zubeda Hamid Edited by Sharmada Venkatasubramanian Learn more about your ad choices. Visit megaphone.fm/adchoices

When I first met Dr. Mitchell Fleisher, it was clear that his approach to healing goes far beyond conventional medicine. A lifelong advocate for homeopathy and holistic care, Dr. Fleisher shared the story of how a lecture during medical school and a personal health breakthrough cemented his commitment to natural healing. We talked about his innovative Joint Regeneration Therapy (JRT), which combines homeopathic remedies, peptides, and nutritional support to help patients avoid invasive procedures. He also discussed the risks of overusing NSAIDs, strategies for supporting children's health naturally, and the importance of empowering individuals with practical tools for self-care. Finally, Dr. Fleisher walked us through his online platform, Alternative Dr. M Care, which provides hundreds of protocols and resources to guide people in taking charge of their own health. Episode Highlights: 08:38 - First Encounter with Homeopathy 12:35 - The moment theory turned real 15:44 - An Integrated Healing Approach 19:17 - Joint Regeneration Therapy (JRT) 23:39 - Her Knee Pain Disappears 25:46 - Comparing JRT to Stem Cell Therapy 29:35 - Concerns About Anti-Inflammatories 32:31 - Safer Alternatives for Teething 40:59 - Overview of GNHS Services 44:01 - What is Alternative DrMCare? 47:27 - Membership Benefits and Updates 49:13 - How Homeopathy Empowers Mothers 57:16 - Generational Impact of Homeopathy About my Guests: Mitchell A. Fleisher, M.D., M.D.(H), D.Ht., D.A.B.F.M., Dc.A.B.C.T., F.S.S.R.P. Dr. Mitch Fleisher is a double board-certified Family Physician with over 40 years of experience in integrative and regenerative medicine. He specializes in constitutional homeopathy, anti-aging therapies, peptide therapy, stem cell and exosome therapy, advanced musculoskeletal injections, nutritional and botanical medicine, IV therapy, chelation, detoxification, bio-oxidative therapy, and bio-identical hormone replacement. He is the originator of Joint Regeneration Therapy (JRT), a natural, non-surgical approach for repairing joints and relieving chronic pain, enhanced with StemWave therapy. Dr. Fleisher has taught homeopathy and integrative medicine at institutions including the University of Virginia Health Sciences Center and the Medical College of Virginia, and continues to lecture nationally and internationally. He is the author of Alternative DrMCare Natural Medical Self-Care Protocols© and Rapid Reference to the Fundamentals of Vitamin Therapy. He serves as Medical Director of the Center for Integrative & Regenerative Medicine (C.I.R.M.) in Virginia and Global Natural Health Solutions (GNHS), providing expert homeopathic and naturopathic consultations worldwide. Find out more about Dr Mitchell Website https://www.gnhshealing.com/ https://www.alternativedrmcare.com/ https://www.cirm1.org/ If you would like to support the Homeopathy Hangout Podcast, please consider making a donation by visiting www.EugenieKruger.com and click the DONATE button at the top of the site. Every donation about $10 will receive a shout-out on a future episode. Join my Homeopathy Hangout Podcast Facebook community here: https://www.facebook.com/groups/HelloHomies Follow me on Instagram https://www.instagram.com/eugeniekrugerhomeopathy/ Here is the link to my free 30-minute Homeopathy@Home online course: https://www.youtube.com/watch?v=vqBUpxO4pZQ&t=438s Upon completion of the course - and if you live in Australia - you can join my Facebook group for free acute advice (you'll need to answer a couple of questions about the course upon request to join): www.facebook.com/groups/eughom          

In this episode, we explore one of today's most requested cosmetic procedures-facial plastic surgery-with a special focus on blepharoplasty, commonly known as eyelid surgery. Renowned Las Vegas board certified plastic surgeon Dr. Jeffrey Roth, shares expert insight into how this procedure can rejuvenate the eyes, restore a more youthful appearance, and even improve vision in some cases. Dr. Roth breaks down the differences between upper and lower eyelid surgery, what candidates should know before considering the procedure, and what to expect during recovery. We also discuss why blepharoplasty continues to be one of the most popular facial procedures for both men and women, and how subtle, natural-looking results can make a powerful impact. If you've ever wondered how to achieve a more refreshed, rested look or are considering eyelid surgery, this episode offers valuable information directly from a trusted Las Vegas expert.  We invite you to contact us with your questions including suggestions for topics to cover on future episodes!  email: inquiry@darrellcraigharris.com Meet Dr. Jeffrey J. Roth from Las Vegas Plastic Surgery Drawn to medicine by his innate desire to help others, he received his medical degree from the University of Nevada School of Medicine. He completed his general surgery residency at the Medical College of Pennsylvania/Hahnemann University in Philadelphia and his plastic surgery residency at the University of California, San Francisco, serving as chief resident in both programs. He then furthered his training with a fellowship in microsurgery and hand surgery at USC, where he also served on the faculty. Having gathered the kind of expertise and experience that makes him a leader in his field, Dr. Roth returned to Las Vegas in 2003 and opened his practice, Las Vegas Plastic Surgery, Inc. Website www.JJRothMD.com  Social media www.Instagram.com/lasvegasplasticsurgery www.Instagram.com/lookinggoodfeelinggreatpodcast www.Facebook.com/lasvegasplasticsurgery www.Twitter.com/DrJeffreyRoth             

Dr. Mary Rosser, obstetrician gynecologist and director of Fazzalari Women's Health at NewYork-Presbyterian The One and Columbia, joins us to explain how the endocrine system functions and how external chemicals can disrupt hormonal signals that influence metabolism, fertility, cancer risk, and long-term health. She details the most common sources of endocrine disruptors — including plastics, personal care items, cleaning products, and pesticides — and shares clear, manageable strategies for reducing everyday exposure. Dr. Rosser's guidance empowers listeners to make small, sustainable changes that can help protect hormonal well‑being.   Chapters: 00:00:00 — Understanding Hormones and Endocrine Disruptors 00:05:01 — Health Effects Linked to Endocrine Disruptors 00:09:55 — Everyday Sources and How to Reduce Exposure 00:17:28 — Can the Body Recover? Practical Steps and Final Takeaways   Key Topics Covered What hormones are and how the endocrine system works What endocrine disruptors are and how they interfere with hormone signaling How endocrine disruptors enter the body (skin, food, air) Health impacts: metabolism, fertility, cancer risk, and chronic conditions Common sources of disruptors (plastics, BPA, phthalates, cosmetics, cleaning products, pesticides, microplastics) Practical ways to reduce exposure in daily life How to monitor hormone health and when to talk to a doctor The body's ability to recover once exposure is reduced   Takeaway Message This episode empowers listeners to understand how everyday chemicals can interfere with the body's delicate hormonal system — and shows that small, practical changes in the products we use and the foods we choose can meaningfully reduce exposure.   Expert Guest Dr. Mary L. Rosser, M.D., Ph.D., NCMP is an obstetrician gynecologist and the director of Fazzalari Women's Health at NewYork-Presbyterian The One and Columbia. She is the Richard U. and Ellen J. Levine Assistant Professor of Women's Health (in Obstetrics and Gynecology) at Columbia University Vagelos College of Physicians & Surgeons. She joined the faculty of Obstetrics and Gynecology at Columbia University in April 2018 to provide routine gynecology care and to further develop a comprehensive well-woman program. She has been a practicing obstetrician gynecologist for more than 20 years, starting in private practice and then joining the faculty at Montefiore Medical Center in Bronx, NY. While at Montefiore, she created, launched, and led the forty-person Division of General Obstetrics and Gynecology. Dr. Rosser received her undergraduate degree at Emory University and a Ph.D. in Endocrinology at the Medical College of Georgia. She attended Wake Forest University School of Medicine and completed her residency at Emory University. She is also a NAMS Certified Menopause Practitioner, able to provide high-quality care for patients at menopause and beyond. Primary care and heart disease in women have always been areas of focus for Dr. Rosser. She conducted basic science research on heart disease during graduate school and was the Chair of the "Women & Heart Disease Physician Education Initiative" for District II of the American College of Obstetrics & Gynecology. She continues to conduct clinical studies around patient awareness and understanding of heart disease and well-woman care. Dr. Rosser serves on the Medical Leadership Team of the Go Red for Women movement of the American Heart Association and she is ACOG's liaison to the American College of Cardiology.  

Hello and welcome to this episode of A Cancer Conversation with the Georgia Cancer Center at Augusta University.If your pain management is not where you want it to be, don't give up hope. Your pain can be managed. If one medication or pain management approach does not work, there is almost always another one to try. Today, we have two guests who will be sharing strategies to help cancer patients deal with the various painful effects of a cancer diagnosis and treatment plan.First, is Dr. Lauren Bigham. Dr. Bigham is the director of the Georgia Cancer Center's Psycho-Social Oncology program. Joining her is Dr. Egidio Del Fabbro. Dr. Del Fabbro is a professor in the Department of Medicine at the Medical College of Georgia at Augusta University, as well as the director of Palliative Medicine at the Georgia Cancer Center.Learn More: https://gccnews.augusta.edu/2026/03/06/the-silent-battle-redefining-cancer-pain-management/#GeorgiaCancerCenter #Cancer #LivingWithCancer #CancerAwareness

Spring is one of the busiest seasons in plastic surgery-and for good reason. In this episode, Dr. Jeffrey J. Roth of Las Vegas Plastic Surgery explains why so many patients choose the spring months to schedule procedures and treatments. From planning recovery time before summer to preparing for vacations, weddings, and special events, timing can play an important role in cosmetic procedures. Dr. Roth discusses the most commonly requested procedures during this time of year and what patients should consider when planning their treatment timeline. If you've ever wondered why spring is considered "plastic surgery season," this episode offers helpful insights into timing, preparation, and achieving your aesthetic goals. We invite you to contact us with your questions including suggestions for topics to cover on future episodes!  email: inquiry@darrellcraigharris.com Meet Dr. Jeffrey J. Roth from Las Vegas Plastic Surgery Drawn to medicine by his innate desire to help others, he received his medical degree from the University of Nevada School of Medicine. He completed his general surgery residency at the Medical College of Pennsylvania/Hahnemann University in Philadelphia and his plastic surgery residency at the University of California, San Francisco, serving as chief resident in both programs. He then furthered his training with a fellowship in microsurgery and hand surgery at USC, where he also served on the faculty. Having gathered the kind of expertise and experience that makes him a leader in his field, Dr. Roth returned to Las Vegas in 2003 and opened his practice, Las Vegas Plastic Surgery, Inc. Website www.JJRothMD.com  Social media www.Instagram.com/lasvegasplasticsurgery www.Instagram.com/lookinggoodfeelinggreatpodcast www.Facebook.com/lasvegasplasticsurgery www.Twitter.com/DrJeffreyRoth             

In this podcast, JPEN Editor-in-Chief Dr. Kenneth Christopher, interviews Arjun N. Bhatt from the Medical College of Georgia at Augusta University. Arjun N. Bhatt is a senior medical student and outcomes researcher. Arjun N. Bhatt is first author of the research article “Association between nonacidified standard and high‐protein human milk fortifiers and increased weight velocity relative to acidified human milk fortifiers in preterm infants: A retrospective cohort study”. Business Corporate by Alex Menco | alexmenco.net Music promoted by www.free-stock-music.com Creative Commons Attribution 3.0 Unported License creativecommons.org/licenses/by/3.0/deed.en_US January 2026

In orthopedic IR, confidence comes from exposure. It's all about getting those reps in. In this BackTable MSK Brief, host Kavi Krishnasamy interviews Dr. Brandon Key from the Medical College of Wisconsin about implementing bone stabilization and fixation in interventional radiology for pathologic and non-pathologic fractures. The doctors discuss key barriers which include limited training exposure and operational inefficiencies that discourage adoption. However, they highlight the evolving technology, vendor toolsets, and growing multidisciplinary collaboration that are mitigating these barriers. The discussion expands to cover trauma-related consults from orthopedic surgery, indications and evolving applications of the IlluminOss device, screw types and preferences, and the capabilities of the Flow-FX cement-delivery device.  Episode Outline 00:00 - Introduction 00:57 - The Delay in Take-Off of Bony Fixation and Stabilization at the Trainee Level  03:10 - Meaningful Multidisciplinary Momentum 05:35 - Treatment of Pathologic Fractures in the Orthopedic IR Space 09:17 - Considerations for Trauma and Fragility Cases 16:09 - Patient Prep and Approach 18:05 - Final Thoughts Resources Dr. Brandon Key, MD https://www.linkedin.com/in/brandon-key-md-367a01310/  IlluminOss https://illuminoss.com/us  Flow-FXhttps://flow-fx.net/products/

What does truly integrated care look like – and what role should dental hygienists play in it? As National Children's Dental Health Month comes to a close, host Matt Crespin sits down with two speakers from ADHA's first-ever Integrated Care Summit to explore how medical-dental integration is reshaping patient care. Nevada hygienist Jessica Woods shares real-world cases – from cardiologist referrals to coordinating airway care for her own daughter – that prove integration isn't just for public health settings. Pediatrician Dr. Connie Gundacker offers a medical perspective, revealing why most physicians receive little to no oral health training and how hygienists can bridge that gap. Together, they make a compelling case: dental hygienists are uniquely positioned to lead integration efforts, if the profession seizes the opportunity. Matt also covers ADHA award nominations, OPA legislative updates and upcoming events. Join these speakers and more at the Integrated Care Summit, May 15–17 in Broomfield, Colorado.Guests: Constance Gundacker, MD, MPH, FAAP, Section Chief of General and Community Pediatrics, Medical College of Wisconsin and Jessica L. Woods, MPH, RDH, FADHA, Chief Executive Officer, Executive RDHHost: Matt Crespin, MPH, RDH, FADHA

Physicians face higher rates of depression, anxiety, and suicide risk than the general population — yet fewer than one in three with a mental health condition ever receives care. In this episode, Dr. Jesse Ehrenfeld, professor of anesthesiology at the Medical College of Wisconsin and Global Chief Medical Officer for AIDOC, discusses what happens when physicians consider getting help. The conversation looks at how concerns about licensing, confidentiality, and other structural barriers can make seeking care feel risky, and why progress has been uneven. You can listen to the first half of the conversation here. Hosted on Acast. See acast.com/privacy for more information.

Dr. Pedro Barata and Dr. Ugwuji Maduekwe discuss the evolving treatment landscape in gastroesophageal junction and gastric cancers, including the emergence of organ preservation as a selective therapeutic goal, as well as strategies to mitigate disparities in care. Dr. Maduekwe is the senior author of the article, "Organ Preservation for Gastroesophageal Junction and Gastric Cancers: Ready for Primetime?" in the 2026 ASCO Educational Book. TRANSCRIPT Dr. Pedro Barata: Hello, and welcome to By the Book, a podcast series from ASCO that features compelling perspectives from authors and editors of the ASCO Educational Book. I'm Dr. Pedro Barata. I'm a medical oncologist at University Hospitals Seidman Cancer Center and an associate professor of medicine at Case Western Reserve University in Cleveland, Ohio. I'm also the deputy editor of the ASCO Educational Book. Gastric and gastroesophageal cancers are the fifth most common cancer worldwide and the fourth leading cause of cancer-related mortality. Over the last decade, the treatment landscape has evolved tremendously, and today, organ preservation is emerging as an attainable but still selective therapeutic goal. Today, I'm delighted to be speaking with Dr. Ugwuji Maduekwe, an associate professor of surgery and the director of regional therapies in the Division of Surgical Oncology at the Medical College of Wisconsin. Dr. Maduekwe is also the last author of a fantastic paper in the 2026 ASCO Educational Book titled "Organ Preservation for Gastroesophageal Junction and Gastric Cancers: Ready for Prime Time?" We explore these questions in our conversations today.  Our full disclosures are available in the transcript of this episode as well. Welcome. Thank you for joining us today. Dr. Ugwuji Maduekwe: Thank you, Dr. Barata. I'm really, really glad to be here. Dr. Pedro Barata: There's been a lot of progress in the treatment of gastric and gastroesophageal cancers. But before we actually dive into some of the key take-home points from your paper, can you just walk us through how systemic therapy has emerged and actually allowed you to start thinking about a curative framework and really informing surgery decision-making? Dr. Ugwuji Maduekwe: Great, thank you. I'm really excited to be here and I love this topic because, I'm terrified to think of how long ago it was, but I remember in medical school, one of my formative experiences and why I got so interested in oncology was when the very first trials about imatinib were coming through, right? Looking at the effect, I remember so vividly having a lecture as a first-year or second-year medical student, and the professor saying, "This data about this particular kind of cancer is no longer accurate. They don't need bone marrow transplants anymore, they can just take a pill." And that just sounded insane. And we don't have that yet for GI malignancies. But part of what is the promise of precision oncology has always been to me that framework. That framework we have for people with CML who don't have a bone marrow transplant, they take a pill. For people with GIST. And so when we talk about gastric cancers and gastroesophageal cancers, I think the short answer is that systemic therapy has forced surgeons to rethink what "necessary" really means, right? We have the old age saying, "a chance to cut is a chance to cure." And when I started out, the conversation was simple. We diagnose the cancer, we take it out. Surgery's the default. But what's changed really over the last decade and really over the last five years is that systemic therapy has gotten good enough to do what is probably real curative work before we ever enter the operating room. So now when you see a patient whose tumor has essentially melted away on restaging, the question has to shift, right? It's no longer just, "Can I take this out?" It's "Has the biology already done the heavy lifting? Have we already given them systemic therapy, and can we prove it safely so that maybe we don't have to do what is a relatively morbid procedure?" And that shift is what has opened the door to organ preservation. Surgery doesn't disappear, but it becomes more discretionary. Necessary for the patients who need it, and within systems that can allow us to make sure that we're giving it to the right patients. Dr. Pedro Barata: Right, no, that makes total sense. And going back to the outcomes that you get with these systemic therapies, I mean, big efforts to find effective regimens or cocktails of therapies that allow us to go to what we call "complete response," right? Pathologic complete response, or clinical complete response, or even molecular complete response. We're having these conversations across different tumors, hematologic malignancies as well as solid tumors, right? I certainly have those conversations in the GU arena as well. So, when we think of pathologic CRs for GI malignancies, right? If I were to summarize the data, and please correct me if I'm wrong, because I'm not an expert in this area, the traditional perioperative chemo gives you pCRs, pathologic complete response, in the single digits. But then when you start getting smarter at identifying biologically distinct tumors such as microsatellite instability, for instance, now you start talking about pCRs over 50%. In other words, half of the patients' cancer goes away, it melts down by offering, in this case, immunotherapy as a backbone of that neoadjuvant. But first of all, this shift, right, from going from these traditional, "not smart" chemotherapy approaches to kind of biologically-driven approaches, and how important is pCR in the context of "Do I really need surgery afterwards?" Dr. Ugwuji Maduekwe: That's really the crux of the entire conversation, right? We can't proceed and we wouldn't be able to have the conversation about whether organ preservation is even plausible if we hadn't been seeing these rates of pathologic complete response. If there's no viable tumor left at resection, did surgery add something? Are we sure? The challenge before this was how frequently that happened. And then the next one is, as you've already raised, "Can we figure that out without operating?" In the traditional perioperative chemo era, pathologic complete response was relatively rare, like maybe one in twenty patients. When we go to more modern regimens like FLOT, it got closer to one in six. When you add immunotherapy in recent trials like MATTERHORN, it's nearly triple that rate. And it's worth noting here, I'm a health services-health disparities researcher, so we'll just pause here and note that those all sound great, but these landmark trials have significant representation gaps that limit and should inform how confidently we generalize these findings. But back to what you just said, right, the real inflection point is MSI-high disease where, with neoadjuvant dual-checkpoint blockade, trials like NEONIPIGAS and INFINITY show pCR rates that are approaching 50% to 60%. That's not incremental progress, that's a whole new different biological reality. What does that mean? If we're saying that 50% to 60% of the people we take to the OR at the time of surgery will end up having no viable tumor, man, did we need to do a really big surgery? But the problem right now is the gold standard, I think we would mostly agree, the gold standard is pathologic complete response, and we only know that after surgery. I currently tell my patients, right, because I don't want them to be like, "Wait, we did this whole thing." I'm like, "We're going to do this surgery, and my hope is that we're going to do the surgery and there will be no cancer left in your stomach after we take out your stomach." And they're like, "But we took out my stomach and you're saying it's a good thing that there's no cancer." And yes, right now that is true because it's a measure of the efficacy of their systemic therapy. It's a measure of the biology of the disease. But should we be acting on this non-operatively? To do that, we have to find a surrogate. And the surrogate that we have to figure out is complete clinical response. And that's where we have issues with the stomach. In esophageal cancer, the preSANO protocol, which we'll talk about a little bit, validated a structured clinical response evaluation. People got really high-quality endoscopies with bite-on biopsies. They got endoscopic ultrasounds. They got fine-needle aspirations and PET-CT, and adding all of those things together, the miss rate for substantial residual disease was about 10% to 15%. That's a number we can work with. In the stomach, it's a lot more difficult anatomically just given the shape of people's stomachs. There's fibrosis, there's ulceration. A fair number of stomach and GEJ cancers have diffuse histology which makes it difficult to localize and they also have submucosal spread. Those all conceal residual disease. I had a recent case where I scoped the patient during the case, and this person had had a 4 cm ulcer prior to surgery, and I scoped and there was nothing visible. And I was elated. And on the final pathology they had a 7 cm tumor still in place. It was just all submucosal. That's the problem. I'm not a gastroenterologist, but I would have said this was a great clinical response, but because it's gastric, there was a fair amount of submucosal disease that was still there. And our imaging loses accuracy after treatment. So the gap between what looks clean clinically and what's actually there pathologically remains very wide. So I think that's why we're trying to figure it out and make it cleaner. And outside of biomarker-selected settings like MSI-high disease, in general, I'm going to skip to the end and our upshot for the paper, which is that organ preservation, I would say for gastric cancer particularly, should remain investigational. I think we're at the point where the biology is increasingly favorable, but our means of measurement is not there yet. Dr. Pedro Barata: Gotcha. So, this is a perfect segue because you did mention the SANO, just to spell it out, "Surgery As Needed for Oesophageal" trial, so SANO, perfect, I love the abbreviation. It's really catchy. It's fantastic, it's actually a well-put-together perspective effort or program applying to patients. And can you tell us how was that put together and how does that work out for patients? Dr. Ugwuji Maduekwe: Yeah, I think for those of us in the GI space, we have SANO and then we also have the OPRA for rectum. SANO for the upper GI is what takes organ preservation from theory to something that's clinically credible. The trial asked a very simple question. If a patient with a GEJ adenocarcinoma or esophageal adenocarcinoma achieved what was felt to be a clinical complete response after chemoradiation, would they actually benefit from immediate surgery? And the question was, "Can you safely observe?" And the answer was 'yes'. You could safely observe, but only if you do it right. And what does that mean? At two years, survival with active surveillance was not inferior to those who received an immediate esophagectomy. And those patients had a better early quality of life. Makes sense, right? Your quality of life with an esophagectomy versus not is going to be different. That matters a lot when you consider what the long-term metabolic and functional consequences of an esophagectomy are. The weight loss, nutritional deficiencies that can persist for years. But SANO worked because it was very, very disciplined and not permissive. You mentioned rigor. They were very elegant in their approach and there was a fair amount of rigor. So there were two main principles. The first was that surveillance was front-loaded and intentional. So they had endoscopies with biopsies and imaging every three to four months in the first year and then they progressively spaced it out with explicit criteria for what constituted failure. And then salvage surgery was pre-planned. So, the return-to-surgery pathway was already rehearsed ahead of time. If disease reappeared, take the patient to the OR within weeks. Not sit, figure out what that means, think about it a little bit and debate next steps. They were very clear about what the plan was going to be. So they've given us this blueprint for, like, watching people safely. I think what's remarkable is that if you don't do that, if you don't have that infrastructure, then organ preservation isn't really careful. It's really hopeful. And that's what I really liked about the SANO trial, aside from, I agree, the name is pretty cool. Dr. Pedro Barata: Yeah, no, that's a fantastic point. And that description is spot on. I am thinking as we go through this, where can this be adopted, right? Because, not surprisingly, patients are telling you they're doing a lot better, right, when you don't get the esophagus out or the stomach out. I mean, that makes total sense. So the question is, you know, how do you see those issues related to the logistics, right? Getting the multi-disciplinary team, getting the different assessments of CR. I guess PETs, a lot of people are getting access to imaging these days. How close do you think this is, this kind of program, to be implemented? And maybe I would assume it might need to be validated in different settings, right, including the community. How close or how far do you think you see that being applied out there versus continuing to be a niche program, watch and wait program, in dedicated academic centers? Dr. Ugwuji Maduekwe: I love this question. So I said at the top of this, I'm a health equity/health disparities researcher, and this is where I worry the most. I love the science of this. I'm really excited about the science. I'm very optimistic. I don't think this is a question of "if," I think it's a question of "when." We are going to get to a point where these conversations will be very, very reasonable and will be options. One of the things I worry about is: who is it going to be an option for? Organ preservation is not just a treatment choice, and I think what you're pointing out very rightly is it's a systems-level intervention. Look at what we just said for SANO. Someone needs to be able to do advanced endoscopy, get the patients back. We have to have the time and space to come back every three to four months. We have to do molecular testing. There needs to be multi-disciplinary review. There needs to be intensive surveillance, and you need to have rapid access to salvage surgery. Where is that infrastructure? In this country, it's mostly in academic centers. I think about the panel we had at ASCO GI, which was fantastic. And as we were having the conversation, you know, we set it up as a debate. So folks were debating either pro-surveillance or pro-surgery. But both groups, both people, were presenting outcomes based on their centers. And it was folks who were fantastic. Dr. Molena, for example, from Memorial Sloan Kettering was talking about their outcomes in esophagectomies [during our session at GI26], but they do hundreds of these cases there per year. What's the reality in this country? 70% to 80% to 90%, depending on which data you look at, of the gastrectomies in the United States occur at low-volume hospitals. Most of the patients at those hospitals are disproportionately uninsured or on government insurance, have lower income and from racial and ethnic minority groups. So if we diffuse organ preservations without the system to support it, we're going to create a two-tiered system of care where whether you have the ability to preserve your organs, to preserve bodily integrity, depends on where you live and where you're treated. The other piece of this is the biomarker testing gap. One of the things that, as you pointed out at the beginning, that's really exciting is for MSI-high tumors. Those are the patients that are most likely to benefit from immunotherapy-based organ preservation. But here's the problem. If the patient isn't tested at time of initial diagnosis before they ever see me as a surgeon, the door to organ preservation is closed before it's ever open. And testing access remains very inconsistent across academic networks. And then there's the financial toxicity piece where, for gastrectomy, pancreatectomy, I do peritoneal malignancies, more than half of those patients experience significant financial toxicity related to their cancer treatment. We're now proposing adding at least two years, that's the preliminary information, right? It's probably going to be longer. At least a couple of years of surveillance visits, repeated endoscopies, immunotherapy costs. How are we going to support patients through that? We're going to have to think about setting up navigation support, geographic solutions, what financial counseling looks like. My patient for clinic yesterday was driving to see me, and they were talking about how they were sliding because it was snowing. And they were sliding for the entire three-hour drive down here. Are we going to tell people like that that they need to drive down to, right, I work at a high-volume center, they're going to need to come here every three months, come rain or snow, to get scoped as opposed to the one-time having a surgery and not needing to have the scopes as frequently? My concern, like I said, I'm an optimist, I think it is going to work. I think we're going to figure out how to make it work. I'm worried about whether when we deploy it, we widen the already existing disparities. Dr. Pedro Barata: Gotcha, and that's a fantastic summary. And as I'm thinking also of what we've been talking in other solid tumors, which one of the following do you think is going to evolve first? So we are starting to use more MRD-based assays, which are based on blood test, whether it's a tumor-informed ctDNA or non-informed. We are also trying to get around or trying to get more information response to systemic therapies out of RNA-seq through gene expression signatures, or development of novel therapeutics which also can help you there. Which one of these areas you think you're going to help this SANO-like approach move forward, or you actually think it's actually all of the above, which makes it even more complicated perhaps? Dr. Ugwuji Maduekwe: I think it's going to be all of the above for a couple of reasons. I would say if I had to pick just one right now, I think ctDNA is probably the most promising and potentially the missing piece that can help us close the gap between clinical and pathologic response. If you achieve clinical complete response and your ctDNA is negative, so you have clinical and molecular evidence of clearance, maybe that's a low-risk patient for surveillance. If you have clinical complete response but your ctDNA remains positive, I would say you have occult molecular disease and we probably need intensified therapy, closer monitoring, not observation. I think the INFINITY trial is already incorporating ctDNA into its algorithm, so we'll know. I don't think we're at the point where it alone can drive surgical decisions. I think it's going to be a good complement to clinical response evaluation, not a replacement. The issue of where I think it's probably going to be multi-dimensional is the evidence base: who are we testing? Like, what is the diversity, what is the ancestral diversity of these databases that we're using for all of these tests? How do we know that ctDNA levels and RNA-seq expression arrays are the same across different ancestral groups, across different disease types? So I think it's probably going to be an amalgam and we're going to have to figure out some sort of algorithm to help us define it based on the patient characteristics. Like, I think it's probably different, some of this stuff is going to be a little bit different depending on where in the stomach the cancer is. And it's going to be a little bit more difficult to figure out if you have a complete clinical response in the antrum and closer to the pylorus, for example. That might be a little bit more difficult. So maybe the threshold for defining what a clinical complete response needs to be is higher because the therapeutic approach there is not quite as onerous as for something at the GE-junction. Dr. Pedro Barata: Wonderful. And I'm sure AI, whether it's digitization of the pathology from the biopsies and putting all this together, probably might play a role as well in the future.  Dr. Maduekwe, it's been fantastic. Thank you so much for sharing your insights with us and also congrats again for the really well-done review published.  For our listeners, thank you for staying with us. Thank you for your time. We will post a link to this fantastic article we discussed today in the transcript of this episode. And of course, please join us again next month on the By the Book Podcast for more insights on key advances and innovations that are shaping modern oncology. Thank you, everyone. Dr. Ugwuji Maduekwe: Thank you. Thank you for having me. Watch the ASCO GI26 session: Organ Preservation for Gastroesophageal and Gastric Cancers: Ready for Primetime? Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:          Dr. Pedro Barata   @PBarataMD    Dr. Ugwuji Maduekwe @umaduekwemd Follow ASCO on social media:          @ASCO on X (formerly Twitter)          ASCO on Bluesky         ASCO on Facebook          ASCO on LinkedIn          Disclosures:       Dr. Pedro Barata:   Stock and Other Ownership Interests: Luminate Medical   Honoraria: UroToday   Consulting or Advisory Role: Bayer, BMS, Pfizer, EMD Serono, Eisai, Caris Life Sciences, AstraZeneca, Exelixis, AVEO, Merck, Ipson, Astellas Medivation, Novartis, Dendreon   Speakers' Bureau: AstraZeneca, Merck, Caris Life Sciences, Bayer, Pfizer/Astellas   Research Funding (Inst.): Exelixis, Blue Earth, AVEO, Pfizer, Merck    Dr. Ugwuji Maduekwe: Leadership: Medica Health Research Funding: Cigna    

Estás escuchando #JUNTOSRadio: Entendiendo la endometriosis. ¿Qué es y cómo distinguirla?, ¿Cómo se trata la endometriosis? ¿Es una enfermedad prevenible? La Dra. Johanna Finkle de Ginecología y Obstetricia nos responde a estas y otras preguntas.   Sobre nuestra invitada: La Dra. Johanna Finkle está interesada en brindar una atención compasiva y basada en evidencia en obstetricia y ginecología. Maneja todas las áreas de cuidado ginecológico, incluyendo consultas anuales de rutina y anticoncepción. Disfruta cuidar a pacientes obstétricas de alto y bajo riesgo y realiza cirugías mínimamente invasivas, como procedimientos vaginales, histeroscópicos y laparoscópicos. Es fluida en español. Además, le interesa la evaluación, diagnóstico y tratamiento del síndrome de ovario poliquístico (SOP), fibromas, adenomiosis, perimenopausia y menopausia, trastornos vulvares, citologías anormales y colposcopias. Tiene pasión por la interrelación entre estas áreas y el manejo del peso corporal, y busca ayudar a sus pacientes con sus metas de peso y bienestar, desde la preconcepción hasta el embarazo, posparto, menopausia y más allá. Antes de unirse al University of Kansas Health System, la Dra. Finkle trabajó durante 11 años en práctica privada, atendiendo partos y realizando cirugías ginecológicas en el área de Kansas City. Durante ese tiempo, se interesó en un enfoque integral del cuidado del paciente. Es una oyente activa que cree en un plan de atención individualizado, enfocándose en la salud de sus pacientes antes, durante y después del embarazo, así como en la perimenopausia y la menopausia. La Dra. Finkle está certificada en medicina de la obesidad, se graduó en la Northwestern Feinberg School of Medicine y completó su residencia en obstetricia y ginecología en el Medical College of Wisconsin.   Recursos informativos en español Links de información sobre endometriosis https://www-fda-gov.translate.goog/.../understanding... Información sobre endometriosis https://endovillage.org/resources   Facebook: @juntosKS Instagram: juntos_ks YouTube: Juntos KS Página web: http://juntosks.org Suscríbete en cualquiera de nuestras plataformas de Podcast: Podbean, Spotify, Amazon Music y Apple Podcast - Juntos Radio Centro JUNTOS 4125 Rainbow Blvd. M.S. 1076, Kansas City, KS 66160   Este programa es únicamente con fines educativos. Para recibir un diagnóstico o tratamiento, consulte a su médico. La información proporcionada por el invitado es responsabilidad de este. No tenemos los derechos de autor de la música que aparece en este video. Todos los derechos de la música pertenecen a sus respectivos creadores

Physicians face higher rates of depression, anxiety, and suicide risk than the general population, yet most never seek mental health care. In this episode, Dr. Jesse Ehrenfeld, professor of anesthesiology at the Medical College of Wisconsin and Global Chief Medical Officer for AIDOC, discusses new JAMA research examining why. The conversation looks at how medical culture, stigma, time constraints and concerns about confidentiality or professional consequences can keep physicians from getting help, even when effective treatment exists. Hosted on Acast. See acast.com/privacy for more information.

Episode 190 - Meryl Kaufman is a speech-language pathologist with over 30 years of clinical practice specializing in speech and swallowing rehabilitation for patients with head and neck cancer. She has worked in multidisciplinary academic medical centers throughout the Southeast, including the Medical College of Georgia, the Medical University of South Carolina, the University of Alabama at Birmingham, and Emory University. She is also a co-founder and former long-term board member of the Head and Neck Cancer Alliance, a nonprofit organization dedicated to prevention, early detection, and awareness of head and neck cancer.  In 2018, she founded Georgia Speech and Swallowing, LLC, a company focused on national advocacy, outreach, education, and product development for individuals who have undergone laryngectomy surgery (removal of the voice box/larynx). She has recently developed, patented, and licensed an alternative method of voice production, offering a low-cost and accessible voice rehabilitation option for laryngectomy patients worldwide. She collaborated with Noah McNeely at Product QuickStart in developing the CAD designs and prototypes to support the product launch. https://www.headandneck.org/team/meryl-kaufman-med-ccc-slp-bcs-s/   https://leader.pubs.asha.org/doi/10.1044/leader.PA2.19092014.30 Product QuickStart: Noah McNeely https://productquickstart.com 'opu probiotics by Tiffany Krumins: https://www.opuprobiotics.com Podcast Website: https://productgeniuspod.com Slightly Annoying Co-Host: Steven Julian https://www.infinitywmg.com/  Podcast Producer: Jodey Smith https://www.jodeysmith.com/ 

Audiologist Marcia Dewey started Froedtert & the Medical College of Wisconsin's Tinnitus and Hyperacusis Program in 2011. Nearly 15 years later, she joins the ASHA Voices podcast to discuss the program's origins and how chronic pain rehabilitation techniques have transformed her practice.Learn More:ASHA: TinnitusASHA Voices: From Surf Rocker to Research Audiologist, Jim Henry Knows TinnitusASHA Voices: What Tinnitus and mTBI Can Mean for Patients

This new mini-series on Behind the Knife will delve into the technical aspects of the Operative Standards for Cancer Surgery, developed through the American College of Surgeons Cancer Research Program. This second episode highlights the thyroid cancer operative standard.Hosts:Tracy Wang, MD, MPH, FACS is a Professor of Surgery and Vice-Chair of Strategic and Professional Development at the Medical College of Wisconsin with a clinical focus on endocrine surgical oncology. Vladmir Neychev, MD, PhD is a Professor of Surgery at the University of Central Florida College of Medicine with a clinical focus on endocrine surgical oncology.Jack Sample, MD (@JackWSample) is a General Surgery Resident at Mayo Clinic Rochester.Guests:Elizabeth Grubbs, MD (@EGrubbsMD) is a Professor of Surgical Oncology at MD Anderson where she specializes in endocrine tumors, with expertise in cancer of the thyroid.David Hughes, MD is a Clinical Associate Professor of Surgery at University of Michigan, where he focuses on surgical diseases of the endocrine system, including a particular focus on the diagnosis and management of papillary thyroid cancer.Learning Objectives: Understand key preoperative and intraoperative aspects of the evaluation and treatment of patients with biopsy-proven papillary thyroid carcinoma (PTC) greater than or equal to 1 cm. Define factors that guide decision making regarding the extent of surgical resection (lobectomy versus total thyroidectomy) for PTC.Links to Papers Referenced in this EpisodeOperative Standards for Cancer Surgery, Volume 2: Thyroid, Gastric, Rectum, Esophagus, Melanomahttps://www.facs.org/quality-programs/cancer-programs/cancer-surgery-standards-program/operative-standards-for-cancer-surgery/purchase/Kindle edition:Amazon.com: Operative Standards for Cancer Surgery: Volume 2, Section 1: Thyroid eBook : Program, American College of Surgeons Clinical Research, Katz, Matthew HG: Kindle StoreImpact of Extent of Surgery on Survival for Papillary Thyroid Cancer Patients Younger Than 45 years. https://pubmed.ncbi.nlm.nih.gov/25337927/ Extent of Surgery Affects Survival for Papillary Thyroid Cancer. https://pubmed.ncbi.nlm.nih.gov/17717441/Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content.  Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Dr. Michael Cooper, Chief of Transplantation at the Medical College of Wisconsin and Chair of the Board of Directors for Donate Life America, shares his perspective on recent media coverage, its impact on the organ donor registry, and what the media is missing about organ transplantation.

Leadership involves risk, uncertainty, and doing what is right, even when it is unpopular. In this episode, we hear from Dr. John Raymond, President and CEO of the Medical College of Wisconsin, as he highlights some of the toughest decisions he has made throughout his career – both personal and professional – and lessons learned along the way. Join us in gathering Dr. Raymond's insights on emerging stronger through adversity and focusing on the contribution, not the climb.

For some people, diabetes can be very hard to control, even with the standard glucose-lowering therapies. Several studies have demonstrated that endogenous hypercortisolism is prevalent among these individuals. What’s the relationship between type 2 diabetes and hypercortisolism, and what do health care providers need to know about that relationship? To help answer those questions, host Aaron Lohr talks with two guests. Vivian A. Fonseca, MD, is a professor of medicine, assistant dean for clinical research, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the section of endocrinology at Tulane University Medical Center in New Orleans. James W. Findling, MD, is a professor of medicine and surgery at the Medical College of Wisconsin. Drs. Fonseca and Findling are authors of an article published in the journal Diabetes Care looking at the CATALYST study: “Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment.” This episode is made possible by support from Corcept Therapeutics Inc. Show notes are available at https://www.endocrine.org/podcast/enp110 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

First, we speak to The Indian Express' Anonna Dutt about Jammu, where a heated controversy over admissions to a new medical college has now grown into a bigger question...whether the college should be running at all.Next, The Indian Express' Kiran Parashar talks about a young woman's murder case that has sent shockwaves across Karnataka. (13:45)In the end, we talk about a proposed US law that could hit countries like India with a 500% tariff. (26:15)Hosted by Ichha SharmaProduced and written by Shashank Bhargava, Niharika Nanda, and Ichha SharmaEdited and mixed by Suresh Pawar

Your bony fixation technique can make (or break) a complex fracture case. In this episode of the BackTable MSK Podcast, host Kavi Krishnasamy welcomes Dr. Brandon Key, interventional radiologist at Medical College of Wisconsin (MCW) in Milwaukee, to discuss bone stabilization techniques in treating pathologic and non-pathologic fractures. --- SYNPOSIS Dr. Key shares insights into his practice, highlighting the importance of multidisciplinary collaboration with orthopedic surgery, the challenges of training in bony fixation, and the evolving technology that aids in these procedures, including the use of IlluminOss Photodynamic nails in complex bone interventions. Several detailed case studies illustrate the practical application and benefits of these advanced techniques, emphasizing their impact on patient outcomes and functionality. --- TIMESTAMPS 00:00 - Introduction02:06 - A Run Down of Bone Stabilization in the IR Space12:54 - What's in the Toolbox?17:51 - Patient Preparation and Procedure Setup29:47 - Combining Fixation with Thermal Ablation34:12 - Introducing the Photodynamic Nail by IlluminOss40:22 - “The Learning Curve” of the Photodynamic Nail47:48 - Dr. Key's Guidance for Practice Building 52:01 - Literature Highlights on IlluminOss 55:01 - Case 1: Anterior Column Disease 01:01:27 - Case 2: Isolated Posterior Column Disease 01:05:37 - Case 3: Non-healing Pathologic Fracture of Pubic Ramus01:09:37 - Case 4: Iliac Wing Fixation with Orthopedic Surgery01:15:40 - Case 5: Sacral Defects01:19:45 - Case 6: Reconstruction of Posterior Iliac Wing 01:23:50 - Post-Procedure Outcomes and Reflections01:29:02 - Final Thoughts: Encouragement for Collaboration and Innovation --- RESOURCES Dr. Brandon Key, MDhttps://www.linkedin.com/in/brandon-key-md-367a01310/ A Prospective Study of the IlluminOss Photodynamic Nail System for Pelvic Stabilization: Treatment of Impending and Actual Fractures from Metastatic Bone Disease, Multiple Myeloma, and Primary Bone Lymphomahttps://pubmed.ncbi.nlm.nih.gov/39281295/ Minimally Invasive Stabilization Using Screws and Cement for Pelvic Metastases: Technical Considerations for the Pelvic "Screw and Glue" Techniquehttps://pubmed.ncbi.nlm.nih.gov/31435131/ IlluminOsshttps://illuminoss.com/us Flow-FXhttps://flow-fx.net/products/

My conversation with Dr Emanuel begins at about 34 minutes Subscribe and Watch Interviews LIVE : On YOUTUBE.com/StandUpWithPete ON SubstackStandUpWithPete Stand Up is a daily podcast. I book,host,edit, post and promote new episodes with brilliant guests every day. This show is Ad free and fully supported by listeners like you! Please subscribe now for as little as 5$ and gain access to a community of over 750 awesome, curious, kind, funny, brilliant, generous soul In Eat Your Ice Cream, renowned health expert Dr. Ezekiel J. Emanuel argues that life is not a competition to live the longest, and that "wellness" shouldn't be difficult; it should be an invisible part of one's lifestyle that yields maximum health benefits with the least work Ezekiel J. Emanuel, MD, PhD, is the Vice Provost for Global Initiatives, the Co-Director of the Healthcare Transformation Institute, and the Diane v.S. Levy and Robert M. Levy University Professor at the University of Pennsylvania Perelman School of Medicine. Emanuel is an oncologist and world leader in health policy and bioethics. He is a Special Advisor to the Director General of the World Health Organization, Senior Fellow at the Center for American Progress, and member of the Council on Foreign Relations.  He was the founding chair of the Department of Bioethics at the National Institutes of Health and held that position until August of 2011. From 2009 to 2011, he served as a Special Advisor on Health Policy to the Director of the Office of Management and Budget and National Economic Council. In this role, he was instrumental in drafting the Affordable Care Act (ACA). Emanuel also served on the Biden-Harris Transition Covid Advisory Board. Dr. Emanuel is the most widely cited bioethicist in history.  He has over 350 publications and has authored or edited 15 books. His recent publications include the books Which Country Has the World's Best Health Care (2020), Prescription for the Future (2017), Reinventing American Health Care: How the Affordable Care Act Will Improve our Terribly Complex, Blatantly Unjust, Outrageously Expensive, Grossly Inefficient, Error Prone System (2014) and Brothers Emanuel: A Memoir of an American Family (2013). In 2008, he published Healthcare, Guaranteed: A Simple, Secure Solution for America, which included his own recommendations for health care reform. Dr. Emanuel regularly contributes to the New York Times, the Washington Post, the Wall Street Journal, The Atlantic, and often appears on BBC, NPR, CNN, MSNBC and other media outlets. He has received numerous awards including election to the National Academy of Medicine, the American Academy of Arts and Sciences, the Association of American Physicians, and the Royal College of Medicine (UK). He has been named a Dan David Prize Laureate in Bioethics, and is a recipient of the AMA-Burroughs Wellcome Leadership Award, the Public Service Award from the American Society of Clinical Oncology, Lifetime Achievement Award from the American Society of Bioethics and Humanities, the Robert Wood Johnson Foundation David E. Rogers Award, President's Medal for Social Justice Roosevelt University, and the John Mendelsohn Award from the MD Anderson Cancer Center. Dr. Emanuel has received honorary degrees from Icahn School of Medicine at Mount Sinai, Union Graduate College, the Medical College of Wisconsin, and Macalester College. In 2023, he became a Guggenheim Fellow. Dr. Emanuel is a graduate of Amherst College. He holds a M.Sc. from Oxford University in Biochemistry, and received his M.D. from Harvard Medical School and his Ph.D. in political philosophy from Harvard University. On YOUTUBE.com/StandUpWithPete ON SubstackStandUpWithPete   Listen rate and review on Apple Podcasts Listen rate and review on Spotify Pete On Instagram Pete on Blue Sky Pete on Threads Pete on Tik Tok Pete on Twitter Pete Personal FB page Stand Up with Pete FB page All things Jon Carroll  Gift a Subscription https://www.patreon.com/PeteDominick/gift Send Pete $ Directly on Venmo  

Possibly the best yarn spun by the Old Naturalist. In this episode the boys go a little outside the comfort zone to talk about a pivotal moment in the Eric Durbin's life. Take a trip back to the 1970's to check out what Eric was doing in the brain lab at the Medical College of Ohio.

Join Dr. Bahar Force, Endocrinologist, Medical Director of the Pituitary Center, and Associate Program Director of the Endocrinology Fellowship Program at Baylor College of Medicine, as she speaks with leading experts Dr. James Findling, Clinical Professor of Endocrinology at the Medical College of Wisconsin, and Dr. Ty Carroll, Visiting Professor of Endocrinology and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Wisconsin Madison, for a clinician-focused conversation on non-neoplastic hypercortisolism. Together, they discuss how common conditions can lead to cortisol elevations that resemble Cushing syndrome, the clinical patterns that raise concern for neoplastic hypercortisolism, and the growing role of the Desmopressin Stimulation Test in helping distinguish between the two. The episode also highlights emerging research, including insights from the Catalyst study and the potential role of cortisol-directed therapy. 

Join Board-Certified Plastic Surgeon Dr. Jeffrey Roth of Las Vegas Plastic Surgery and co-host Darrell Craig Harris as they break down exactly what it takes to become a plastic surgeon. From the years of medical school and residency training to the intense commitment, discipline, and hands-on experience required, this episode gives a clear, insider look at the full journey. Perfect for future medical students, anyone considering a surgical specialty, or listeners curious about the path behind one of the most competitive fields in medicine. We invite you to contact us with your questions including suggestions for topics to cover on future episodes!  email: inquiry@darrellcraigharris.com Meet Dr. Jeffrey J. Roth from Las Vegas Plastic Surgery Drawn to medicine by his innate desire to help others, he received his medical degree from the University of Nevada School of Medicine. He completed his general surgery residency at the Medical College of Pennsylvania/Hahnemann University in Philadelphia and his plastic surgery residency at the University of California, San Francisco, serving as chief resident in both programs. He then furthered his training with a fellowship in microsurgery and hand surgery at USC, where he also served on the faculty. Having gathered the kind of expertise and experience that makes him a leader in his field, Dr. Roth returned to Las Vegas in 2003 and opened his practice, Las Vegas Plastic Surgery, Inc. Website www.JJRothMD.com  Social media www.Instagram.com/lasvegasplasticsurgery www.Instagram.com/lookinggoodfeelinggreatpodcast www.Facebook.com/lasvegasplasticsurgery www.Twitter.com/DrJeffreyRoth           

Diabetes is becoming increasingly common among young adults, raising important questions about lifestyle, healthcare access, and long-term wellbeing. In this episode, we sit down with Catherine Davis, MD, from the Medical College of Georgia to unpack the latest findings and better understand why this trend is on the rise. We explore current research, discuss prevention strategies, and highlight how Augusta University is helping shape the future of diabetes care through innovation, education, and treatment.Learn more about the Medical College of Georgia: https://www.augusta.edu/mcg

After 6 years of bringing listeners key insights into the most pressing topics in oncology, ACCC's podcast, CANCER BUZZ, has gotten a facelift! In this episode, CANCER BUZZ brings back our first podcast guest, Tina Curtis, DNP, MBA, RN, NEA-BC, executive director of cancer services at Froedtert Hospital. In the June 26, 2019, inaugural CANCER BUZZ episode, Dr. Curtis spoke about her institution's 24-hour, oncology-only urgent care clinic, which earned the cancer program a 2018 ACCC Innovator Award. Today, she's returned with her colleague Jayme Cotter to share an update on that program, as well as recent innovations happening at Froedtert Hospital. "I would venture to guess I've probably talked to no less than 20 or 25 different organizations that found out about the 24-hour urgent care clinic through ACCC's journal and podcast…to have meaningful conversations about where and how to start." Tina Curtis "Another piece that we are looking at expanding is the ability to have a virtual visit from the 24-hour clinic advanced practice providers." Jayme Cotter Guests Tina Curtis, DNP, MBA, RN, NEA-BC Executive Director of Cancer Services Froedtert & the Medical College of Wisconsin Clinical Cancer Center, Froedtert Hospital Campus Milwaukee, WI   Jayme Cotter, DNP, RN, ACNS-BC, AOCNS Director for Clinical Practice & Program Development for the Cancer Service Line Froedtert & the Medical College of Wisconsin Clinical Cancer Center, Froedtert Hospital Campus Milwaukee, WI   Additional Resources: A Pilot 24-Hour Urgent Care Oncology Clinic Reduces ED Use and Cuts Costs Ochsner Chemotherapy Care Companion: Improving Outcomes through Digital Medicine Leveraging Technology to Develop an Express Symptom Management Program & Prevent ED Visits Expediting Cancer Treatment Through a Rapid Access APP-Led Diagnostic Clinic Shaw at Home: An Oncology Specific Home and Community-Based Palliative Care Program – [Mini Podcast] Ep 193 Delivering Hospital Level Acute Care at Home: Learning from Huntsman at Home

Closing the Gap: Understanding Gender Disparities in Bladder Cancer Care, hosted by Martha K. Terris, MD, FACS, is a limited series spotlighting unique considerations for bladder cancer diagnosis and treatment among women. Dr Terris is department chair and a professor in the Department of Urology, the Witherington Distinguished Chair in Urology, and co-director of the Cancer Center at the Medical College of Georgia at Augusta University. In the final part of this 3-part series, Dr Terris discussed how the early diagnosis of bladder cancer presents a significant challenge, particularly in female patients, who are frequently diagnosed at a later stage of the disease and subsequently respond less favorably to treatment modalities. A crucial component of early detection is the rigorous evaluation of hematuria, she emphasized. Microhematuria is defined strictly by microscopy. Reliance solely on a dipstick test is insufficient; any positive dipstick result necessitates a microscopic examination, she explained. Furthermore, patients currently receiving anticoagulation therapy do not bypass the standard workup, she noted. If hematuria is identified alongside a urinary tract infection or gynecological issue, the urine should be rechecked once the co-existing problem has cleared, she advised. Risk assessment must consider both common and less-recognized factors, particularly in women, according to Terris. Standard risks include exposure to cyclophosphamide or ifosfamide, Lynch syndrome, chronic indwelling Foley catheters, benzene/aromatic amine exposure, and smoking, she added. However, uro-oncologists must actively assess female patients for occupational exposures not traditionally associated with bladder cancer, she said. Patients presenting with microhematuria should be stratified into low-, intermediate-, or high-risk groups, Terris continued. The gold standard evaluation for high-risk patients is a cystoscopy and CT urogram, she reported. The CT urogram involves cross-sectional imaging of the abdomen and pelvis with and without contrast, incorporating delayed images to optimally visualize the renal pelvis and ureters for potential filling defects, she noted. If patients cannot tolerate contrast, an MR urogram is the primary alternative, she stated. If neither CT nor MR urogram can be performed, the default workup is non-contrast CT combined with cystoscopy and retrograde pyelograms, although this requires general anesthesia, she explained. Given that women are often diagnosed with bladder cancer late and face poor outcomes with advanced disease, maintaining a heightened awareness and low threshold for investigation is critical, Terris concluded.

Dr. Roth from Las Vegas Plastic Surgery breaks down the most effective approaches to today's modern facelift-exploring techniques, trends, and the evolving "fashion of facelifts." Tune in for a clear, informative look at how contemporary facelift strategies help patients achieve natural, refreshed results. We invite you to contact us with your questions including suggestions for topics to cover on future episodes!  email: inquiry@darrellcraigharris.com Meet Dr. Jeffrey J. Roth from Las Vegas Plastic Surgery Drawn to medicine by his innate desire to help others, he received his medical degree from the University of Nevada School of Medicine. He completed his general surgery residency at the Medical College of Pennsylvania/Hahnemann University in Philadelphia and his plastic surgery residency at the University of California, San Francisco, serving as chief resident in both programs. He then furthered his training with a fellowship in microsurgery and hand surgery at USC, where he also served on the faculty. Having gathered the kind of expertise and experience that makes him a leader in his field, Dr. Roth returned to Las Vegas in 2003 and opened his practice, Las Vegas Plastic Surgery, Inc. Website www.JJRothMD.com  Social media www.Instagram.com/lasvegasplasticsurgery www.Instagram.com/lookinggoodfeelinggreatpodcast www.Facebook.com/lasvegasplasticsurgery www.Twitter.com/DrJeffreyRoth           

Closing the Gap: Understanding Gender Disparities in Bladder Cancer Care, hosted by Martha K. Terris, MD, FACS, is a limited series spotlighting unique considerations for bladder cancer diagnosis and treatment among women. Dr Terris is department chair and a professor in the Department of Urology, the Witherington Distinguished Chair in Urology, and co-director of the Cancer Center at the Medical College of Georgia at Augusta University. In part 2 of this 3-part series, Dr Terris discussed the disparities in treatment and outcomes for women with bladder cancer. Although bladder cancer is less common in females than in males, female patients tend to have significantly worse outcomes, Terris explained. Delayed diagnosis is a contributing factor, but the exact reasons for the poorer prognosis are not fully understood, she emphasized. Treatment difficulties begin surgically, according to Terris. From a surgical perspective, she noted that, performing a cystectomy on a woman is more challenging due to factors like pelvic varicosities and differing fat distribution, which complicate stoma creation. In terms of medical treatment, Terris also explained that women exhibit worse tolerability and higher rates of discontinuation of immunotherapy, and that they often experience poor efficacy outcomes regardless of whether they complete the course of treatment. These differences between men and women may be linked to factors such as hormonal influences or antibody introduction during pregnancy. Conversely, classic cisplatin-based neoadjuvant chemotherapy followed by radical cystectomy have been shown to have similar overall survival and disease-free survival in eligible female and male patients. Biologically, Terris also reported that tumors in women may exhibit more effective immune escape mechanisms, possibly connected to differences in the bladder microbiome. The presence of bacteria in bladder tumors has been found to be enriched in patients who did not respond to neoadjuvant chemotherapy, which is relevant as women are more prone to bladder colonization, she added. Overall, Terris emphasized that oncologists must be aggressive in treating women with bladder cancer, despite surgical complexities, and highlighted that early detection is key.

Dr. Douglas J. Davis, MD, PhD is MCW Office of Global Health Liaison, Department of Radiology, Medical College of Wisconsin----------Ukraine's Winter War Is the World's Test — and America Can't Afford to BlinkOPINION — Two weeks ago, my colleagues and I stood in Dnipro while warning sirens cut across the city and Shahed drones screamed overhead. We had come as a medical-humanitarian delegation to inspect [...] More----------LINKS: https://www.thecipherbrief.com/experts/dr-douglas-j-davis-md-phd https://www.linkedin.com/in/douglas-davis-md-phd-86a9bb3/ ----------DESCRIPTION:The Geopolitical and Strategic Impacts of Russia's War in Ukraine: An Expert AnalysisDr. Douglas Davis, a Ukrainian by marriage and a noted medical professional, delves deep into the geopolitical and strategic significance of Russia's war in Ukraine. With Jonathan as the host, Dr. Davis discusses his personal connection to Ukraine and the broad range of activities he is involved in to support the nation. The conversation spans several key topics including the criticality of defending Karska, the evolving dynamics of authoritarian regimes, the implications of an intensified war in Ukraine, and the potential geopolitical maneuvers by Russia. This episode also touches on the innovative cycles in military technology and the broader implications for global security. Dr. Davis provides an insightful analysis into both historical and contemporary strategies employed by Russia and its allies, laying bare the complexities of modern warfare and the political landscape.----------CHAPTERS:00:00 Introduction to Dr. Douglas Davis and His Connection to Ukraine00:51 Douglas Davis' Personal and Professional Background03:01 Historical Context and Geopolitical Insights04:48 The Ideological and Strategic Threat of Russia19:09 The Critical Battle for Kursk and Its Implications30:29 The Broader Geopolitical Landscape and Authoritarian Alliances42:42 Technological Warfare and Innovation Cycles50:40 Conclusion and Final Thoughts----------SUPPORT THE CHANNEL:https://www.buymeacoffee.com/siliconcurtainhttps://www.patreon.com/siliconcurtain----------TRUSTED CHARITIES ON THE GROUND:Save Ukrainehttps://www.saveukraineua.org/Superhumans - Hospital for war traumashttps://superhumans.com/en/UNBROKEN - Treatment. Prosthesis. Rehabilitation for Ukrainians in Ukrainehttps://unbroken.org.ua/Come Back Alivehttps://savelife.in.ua/en/Chefs For Ukraine - World Central Kitchenhttps://wck.org/relief/activation-chefs-for-ukraineUNITED24 - An initiative of President Zelenskyyhttps://u24.gov.ua/Serhiy Prytula Charity Foundationhttps://prytulafoundation.orgNGO “Herojam Slava”https://heroiamslava.org/kharpp - Reconstruction project supporting communities in Kharkiv and Przemyślhttps://kharpp.com/NOR DOG Animal Rescuehttps://www.nor-dog.org/home/----------

Closing the Gap: Understanding Gender Disparities in Bladder Cancer Care, hosted by Martha K. Terris, MD, FACS, is a limited series spotlighting unique considerations for bladder cancer diagnosis and treatment among women. Dr Terris is department chair and a professor in the Department of Urology, the Witherington Distinguished Chair in Urology, and co-director of the Cancer Center at the Medical College of Georgia at Augusta University.  In part 1 of this 3-part series, Dr Terris discussed the prevalence of bladder cancer in women, as well as reasons for diagnostic disparities that contribute to poor treatment outcomes. She noted that this disease is often diagnosed at later stages in women than in men, often resulting in diagnoses of more advanced disease and translating to poorer outcomes. She added that although female patients represent a minority of those with urothelial carcinoma, retrospective data indicate that women tend to be diagnosed at later stages and consequently experience worse survival rates, regardless of the disease stage. Dr Terris identified several theories explaining why this diagnosis delay occurs. One possible reason is patient-related: women may be less likely than men to consult a physician when they notice blood in their urine because they may be conditioned to dismiss blood if they experience menstrual bleeding. However, physician behavior and bias also contribute to diagnostic disparities, Terris said. Women with suspected hematuria typically receive fewer imaging tests, she continued. Additionally, physicians may be biased, attributing hematuria to uterine bleeding, menstruation, or other benign causes.  Overall, Terris emphasized that early detection is key. If there is any suspicion of a malignancy, patients should be referred directly to a urologist, she stated. Urologists should be willing to work up cases that might ultimately be recurrent urinary tract infections or radiation cystitis to avoid undiagnosed cases of bladder cancer in women, she concluded.

Are you ready to challenge the myths of aging and discover how to stay strong, vital, and resilient for decades to come? In this episode of the Thyroid Answers Podcast, Dr. Eric Balcavage sits down with Dr. Mani Kukreja to explore the cutting-edge science of healthy aging. We dive into: Why aging is not just about years—but about cellular health and resilience The hidden role of thyroid physiology in longevity and vitality Nutrition, movement, and lifestyle strategies that slow the aging clock The difference between simply "managing" disease and truly recovering health Practical steps you can take now to age stronger and live longer And more ... This episode is packed with valuable insights for anyone seeking to protect their thyroid, boost energy, and thrive throughout midlife and beyond. Dr. Mani Kukreja is a medically trained wellness advocate and the founder of LivAgeWell, a comprehensive wellness platform dedicated to optimizing health and preventing disease. With a background in medicine and a Master of Public Health in Clinical Research from Tulane University, Dr. Kukreja combines her extensive medical training with cutting-edge wellness strategies. Her career spans leadership roles at the University of Alabama at Birmingham's Cardiovascular Surgical Research Program and the Medical College of Wisconsin Cancer Research Program, where she directed clinical research operations. She is a sought-after keynote speaker and educator, recognized for her expertise in health optimization, biohacking, and disease prevention. Her holistic approach integrates evidence-based medicine with nutritional science and lifestyle modifications. Featured in Authority Magazine, The Daily Star, Grit Daily, and other leading publications, Dr. Kukreja is an entrepreneur, author, and thought leader who is transforming lives by making personalized wellness accessible to all. She empowers women to take control of their health through science-backed lifestyle changes. Dr Mani's contact information: https://manikukreja.com/ https://www.instagram.com/dr.mani.kukreja/

Welcome to Fertility & Sterility Roundtable! Each month, we will host a discussion with the authors of "Views and Reviews" and "Fertile Battle" articles published in a recent issue of Fertility & Sterility. This month, we welcome Dr. Brian Levine and Dr. Kate Schoyer to discuss if physicians should be facilitating gestational carrier arrangements in the absence of a medical indication, also known as elective surrogacy. Dr. Brian Levine is the founding partner and practice director of CCRM New York, where he has helped countless families on their path to parenthood. Dr. Levine is also the founder of Nodal, the premier online gestational surrogacy platform, which connects intended parents and surrogates in a trusted and transparent way. Dr. Kate Schoyer is an Associate Professor of Obstetrics and Gynecology and Reproductive Endocrinology and Infertility at the Medical College of Wisconsin. She is the Director of the Division of Reproductive Endocrinology and Infertility and is the Medical Director of the Reproductive Medicine Center at Froedtert Hospital. Her research interests include factors contributing to success with ART, the impact of BMI, and therapies for patients with diminished ovarian reserve. View Fertility and Sterility at https://www.fertstert.org/

In this episode, Dr. Roth dives into the topic of otoplasty—a procedure more commonly known as "ear pinning." He explains what it is, who it's for, and what patients can expect from the surgery. What is Otoplasty? Otoplasty, often called ear pinning surgery, is a cosmetic procedure that reshapes or repositions the ears to improve their appearance. It's typically done to reduce the prominence of ears that stick out too far from the head, but it can also correct ear shape irregularities caused by injury, genetics, or previous surgery. We invite you to contact us with your questions including suggestions for topics to cover on future episodes!  email: inquiry@darrellcraigharris.com Meet Dr. Jeffrey J. Roth from Las Vegas Plastic Surgery Drawn to medicine by his innate desire to help others, he received his medical degree from the University of Nevada School of Medicine. He completed his general surgery residency at the Medical College of Pennsylvania/Hahnemann University in Philadelphia and his plastic surgery residency at the University of California, San Francisco, serving as chief resident in both programs. He then furthered his training with a fellowship in microsurgery and hand surgery at USC, where he also served on the faculty. Having gathered the kind of expertise and experience that makes him a leader in his field, Dr. Roth returned to Las Vegas in 2003 and opened his practice, Las Vegas Plastic Surgery, Inc. Website www.JJRothMD.com  Social media www.Instagram.com/lasvegasplasticsurgery www.Instagram.com/lookinggoodfeelinggreatpodcast www.Facebook.com/lasvegasplasticsurgery www.Twitter.com/DrJeffreyRoth         

Send us a textIn this episode, I had the pleasure of speaking with Dr Isabella Eiler from the Medical College of Wisconsin, Milwaukee, Wisconsin. She is originally from the Milwaukee area and first attended the Medical College of Wisconsin for medical school. She then went on to complete her pediatric residency at the Indiana University School of Medicine. In this episode of Rupa's Fellows Friday, Dr. Isabella Eiler discusses her journey in neonatology, particularly her interest in NeuroNICU and hypoxic ischemic encephalopathy (HIE). She shares insights from her research on missed opportunities for neonatal assessments and the importance of multidisciplinary collaboration in improving patient care. Dr. Eiler emphasizes the significance of mentorship during fellowship and the impact of social determinants on neonatal follow-up care. She also reflects on the challenges faced in research and offers valuable advice for future neonatology fellows. Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

In this episode of our Looking Good Feeling Great podcast series, board-certified plastic surgeon Dr. Jeffrey Roth of Las Vegas Plastic Surgery joins co-host Darrell Craig Harris to explore the benefits of Breast Reduction Surgery. Together, they discuss how this procedure can significantly enhance a patient's overall health, comfort, and quality of life. We invite you to contact us with your questions including suggestions for topics to cover on future episodes!  email: inquiry@darrellcraigharris.com Meet Dr. Jeffrey J. Roth from Las Vegas Plastic Surgery Drawn to medicine by his innate desire to help others, he received his medical degree from the University of Nevada School of Medicine. He completed his general surgery residency at the Medical College of Pennsylvania/Hahnemann University in Philadelphia and his plastic surgery residency at the University of California, San Francisco, serving as chief resident in both programs. He then furthered his training with a fellowship in microsurgery and hand surgery at USC, where he also served on the faculty. Having gathered the kind of expertise and experience that makes him a leader in his field, Dr. Roth returned to Las Vegas in 2003 and opened his practice, Las Vegas Plastic Surgery, Inc. Website www.JJRothMD.com  Social media www.Instagram.com/lasvegasplasticsurgery www.Instagram.com/lookinggoodfeelinggreatpodcast www.Facebook.com/lasvegasplasticsurgery www.Twitter.com/DrJeffreyRoth